Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,148 public trials 2,022 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Recruiting

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

NCT07392892

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Rocky Mountain Cancer Centers, LLP Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers, LLP Boulder, Colorado, United States
  • Rocky Mountain Cancer Centers, LLP Centennial, Colorado, United States
  • Rocky Mountain Cancer Centers, LLP Colorado Springs, Colorado, United States
View all 70 locations
View Trial Details
Recruiting

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

NCT06252649

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Ironwood Cancer and Research Centers Scottsdale Chandler, Arizona, United States
  • Providence Saint Jude Medical Center Fullerton, California, United States
  • City of Hope National Medical Center Long Beach, California, United States
  • Cancer and Blood Research Center, LLC Los Alamitos, California, United States
View all 291 locations
View Trial Details
Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

NCT07094113

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 39 locations
View Trial Details
Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT04657068

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adnexal Diseases, +55 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic (Arizona) Scottsdale, Arizona, United States
  • University of Arkansas - Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 82 locations
View Trial Details
Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

NCT05267626

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +57 more
Locations
  • Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Minnesota Oncology and Hematology PA Minneapolis, Minnesota, United States
  • Washington University St Louis, Missouri, United States
View all 18 locations
View Trial Details
Recruiting

A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)

NCT07405151

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • UPMC Hillman Cancer Center ( Site 3904) Pittsburgh, Pennsylvania, United States
  • Liga Norte Riograndense Contra o Cancer ( Site 3301) Natal, Rio Grande do Norte, Brazil
  • Beijing Cancer Hospital ( Site 2500) Beijing, Beijing Municipality, China
  • Masarykuv onkologicky ustav ( Site 4000) Brno, Brno-mesto, Czechia
View all 23 locations
View Trial Details

Related conditions